logo

Valeant Pharmaceuticals International (VRX)



Trade VRX now with
  Date
  Headline
1/12/2018 7:01:48 AM Ortho Dermatologics Announces FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form
1/9/2018 7:02:24 AM Valeant Projects Seven Key Products To Generate $1 Bln In Sales In 5 Years
1/8/2018 8:11:59 AM Bausch + Lomb Receives CE Mark From European Commission For Stellaris Elite Vision Enhancement System
1/7/2018 9:50:22 AM New Drugs Approved In December
1/3/2018 9:03:30 AM Valeant Pays Down $300 Mln Of Senior Secured Term Loans
12/18/2017 8:13:25 AM Bausch + Lomb Begins Distribution Of VYZULTA, 0.024% To U.S. Wholesalers
12/15/2017 9:20:03 PM Valeant And One Of Its Subsidiaries Say Early Tender Results And Settlement Date For Cash Tender Offers For Senior Notes
12/14/2017 3:33:45 PM Valeant Pharmaceuticals Showing Significant Move To The Downside
12/7/2017 10:48:10 PM New Drugs Approved In November
12/4/2017 7:23:02 AM Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1 Bln
12/4/2017 7:21:20 AM Valeant Announces Launch Of Private Offering Of $1 Bln Of Senior Notes Due 2025
11/13/2017 7:37:19 AM Valeant Pharma Launches Offering Of $750 Mln Of 5.500% Senior Secured Notes Due 2025
11/10/2017 7:03:09 AM Valeant PharmaCompletes Sale Of Obagi Medical Products Business